⌘K
Loading ticker…
Lifevantage Corporation Common Stock (Delaware) · Healthcare · Pharmaceutical Products
As of 2026-06-26, Lifevantage Corporation Common Stock (Delaware) (LFVN) has a 3-month relative strength percentile of 90 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 20.2%, relative volume 1.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 90, Market Stance is mixed at 47, A/D rating C
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
LFVN is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $1M notional. Top 3 carry $3M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $1M |
| IWMiShares Russell 2000 ETF | 0.00% | $1M |
| VXFVanguard Extended Market ETF | 0.00% | $479K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $395K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LFVN Jan avg: 0.69% median: -1.99% win: 50% σ: 16.44% n: 4 2022-04-12 → 2026-05-29 | LFVN Feb avg: -1.42% median: -7.63% win: 25% σ: 20.94% n: 4 2022-04-12 → 2026-05-29 | LFVN Mar avg: -10.24% median: -9.38% win: 0% σ: 3.75% n: 4 2022-04-12 → 2026-05-29 | LFVN Apr avg: -4.26% median: -8.08% win: 40% σ: 13.59% n: 5 2022-04-12 → 2026-05-29 | LFVN May avg: 26.54% median: 24.75% win: 100% σ: 22.18% n: 5 2022-04-12 → 2026-05-29 | LFVN Jun avg: -4.06% median: -3.21% win: 50% σ: 9.26% n: 4 2022-04-12 → 2026-05-29 (current) | LFVN Jul avg: 9.35% median: 7.01% win: 50% σ: 15.17% n: 4 2022-04-12 → 2026-05-29 | LFVN Aug avg: 10.40% median: 0.85% win: 50% σ: 24.31% n: 4 2022-04-12 → 2026-05-29 | LFVN Sep avg: 1.85% median: -9.31% win: 25% σ: 34.28% n: 4 2022-04-12 → 2026-05-29 | LFVN Oct avg: 2.27% median: 4.31% win: 75% σ: 13.56% n: 4 2022-04-12 → 2026-05-29 | LFVN Nov avg: -4.91% median: -11.53% win: 25% σ: 16.83% n: 4 2022-04-12 → 2026-05-29 | LFVN Dec avg: 1.05% median: -2.72% win: 25% σ: 13.25% n: 4 2022-04-12 → 2026-05-29 |